What is the share price of Krsnaa Diagnostics Ltd (KRSNAA) today?
The share price of KRSNAA as on 19th June 2026 is ₹531.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Krsnaa Diagnostics Ltd (KRSNAA) share?
The past returns of Krsnaa Diagnostics Ltd (KRSNAA) share are- Past 1 week: -2.13%
- Past 1 month: -5.96%
- Past 3 months: -10.72%
- Past 6 months: -26.10%
- Past 1 year: -23.56%
- Past 3 years: -8.88%
- Past 5 years: -46.17%
What are the peers or stocks similar to Krsnaa Diagnostics Ltd (KRSNAA)?
The peers or stocks similar to Krsnaa Diagnostics Ltd (KRSNAA) include:What is the dividend yield % of Krsnaa Diagnostics Ltd (KRSNAA) share?
The current dividend yield of Krsnaa Diagnostics Ltd (KRSNAA) is 0.37.What is the market cap of Krsnaa Diagnostics Ltd (KRSNAA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krsnaa Diagnostics Ltd (KRSNAA) is ₹1723.47 Cr as of 19th June 2026.What is the 52 week high and low of Krsnaa Diagnostics Ltd (KRSNAA) share?
The 52-week high of Krsnaa Diagnostics Ltd (KRSNAA) is ₹894.40 and the 52-week low is ₹515.What is the PE and PB ratio of Krsnaa Diagnostics Ltd (KRSNAA) stock?
The P/E (price-to-earnings) ratio of Krsnaa Diagnostics Ltd (KRSNAA) is 16.99. The P/B (price-to-book) ratio is 1.95.Which sector does Krsnaa Diagnostics Ltd (KRSNAA) belong to?
Krsnaa Diagnostics Ltd (KRSNAA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Krsnaa Diagnostics Ltd (KRSNAA) shares?
You can directly buy Krsnaa Diagnostics Ltd (KRSNAA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Krsnaa Diagnostics Ltd
KRSNAA Share Price
NSE₹531.300.44% (-2.35)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
KRSNAA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
KRSNAA Performance & Key Metrics
KRSNAA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 17.00 | 1.95 | 0.37% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 41.31 | 6.16 | 0.56% |
100%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
KRSNAA Company Profile
The Company provides diagnostic services. It provides radiology and pathology services for X-rays, CT scan, magnetic resonance imaging (MRI), mammography, tele reporting X-ray and all types of blood and urine investigations.
APOLLOHOSP
PE Ratio
62.87
62.87
1Y Return
21.11%
21.11%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
73.87
73.87
1Y Return
5.87%
5.87%
Buy Reco %
82.61
82.61
FORTIS
PE Ratio
69.78
69.78
1Y Return
28.72%
28.72%
Buy Reco %
84.21
84.21
ASTERDM
PE Ratio
107.79
107.79
1Y Return
41.65%
41.65%
Buy Reco %
100.00
100.00
PE Ratio
47.36
47.36
1Y Return
0.26%
0.26%
Buy Reco %
85.71
85.71
KRSNAA Sentiment Analysis
KRSNAA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
KRSNAA Stock Summary · May 2026
Management presented a picture of solid financial momentum paired with substantial near‑term investment, reporting FY'26 revenue of INR 7,728 million and an EBITDA margin of roughly 27.8%. They highlighted record profitability with PAT crossing INR 1,014 million and stressed a mission‑driven, PPP‑led strategy to build an integrated radiology and pathology platform that requires upfront capital but creates a durable operational moat. Strategic priorities center on completing large projects—notably the Rajasthan rollout and radiology expansion—scaling retail monetization off existing PPP infrastructure, and protecting cash collections while accepting quarter‑to‑quarter margin volatility during ramp phases. Management acknowledged operational tensions: a capital‑intensive FY'27 capex programme of INR 500 crore and a sizable hiring push for Rajasthan will weigh on near‑term margins and caused some timing delays in radiology revenue and state receivables, which they attribute to administrative factors and are actively addressing. For the near term they reiterated long‑term revenue visibility of INR 6,000–7,000 crore over 5–7 years, a target to sustain ~29–30% annualized EBITDA margins, and plans to bring Rajasthan and phased radiology capacity into revenue this year.
KRSNAA Stock Growth Drivers
KRSNAA Stock Growth Drivers
12Mission-driven PPP-led national diagnostic platform
Krsnaa has explicitly positioned itself as a purpose-led diagnostic platform focused on serving Bharat through
Large-scale operational footprint and clinical throughput
The company now operates a substantial integrated network—190+ CT/MRI centers, 147 pathology laboratories, over 4,700
KRSNAA Stock Challenges
KRSNAA Stock Challenges
7Elevated receivables and government counterparty/payment risk
Receivables have stretched materially beyond targets, undermining liquidity and increasing counterparty concentration risk. The company
Capex funding uncertainty and heightened leverage risk during expansion
Planned and already incurred capital expenditures create funding ambiguity and raise leverage concerns as the
KRSNAA Forecast
KRSNAA Forecasts
Price
Revenue
Earnings
KRSNAA Share Price Forecast
KRSNAA Share Price Forecast
2026
Current
₹531.30
Baseline
Forecast for Jun 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹531.30
Baseline
Forecast for Jun 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
KRSNAA Company Revenue Forecast
KRSNAA Company Revenue Forecast
2026
Current
₹816.16
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹816.16
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
KRSNAA Stock EPS (Earnings Per Share) Forecast
KRSNAA Stock EPS (Earnings Per Share) Forecast
2026
Current
₹31.30
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹31.30
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
KRSNAA
KRSNAA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
KRSNAA Income Statement
KRSNAA Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 162.40 | 170.62 | 177.55 | 190.93 | 183.75 | 190.46 | 196.94 | 210.17 | 184.97 | 224.10 | ||||||||||
Operating & Other expenses | 120.93 | 122.58 | 127.56 | 136.94 | 129.44 | 133.09 | 141.58 | 146.84 | 134.84 | 137.73 | ||||||||||
EBITDA | 41.47 | 48.04 | 49.99 | 53.99 | 54.31 | 57.37 | 55.36 | 63.33 | 50.13 | 86.37 | ||||||||||
| Depreciation/Amortization | 21.23 | 18.12 | 21.47 | 22.20 | 22.70 | 21.96 | 21.63 | 23.59 | 22.66 | 22.59 | ||||||||||
| PBIT | 20.24 | 29.92 | 28.52 | 31.79 | 31.61 | 35.41 | 33.73 | 39.74 | 27.47 | 63.78 | ||||||||||
| Interest & Other Items | 4.15 | 7.32 | 5.32 | 6.39 | 6.13 | 6.81 | 6.30 | 8.19 | 7.79 | 12.08 | ||||||||||
| PBT | 16.09 | 22.60 | 23.20 | 25.40 | 25.48 | 28.60 | 27.43 | 31.55 | 19.68 | 51.70 | ||||||||||
| Taxes & Other Items | 3.13 | 3.88 | 5.29 | 5.81 | 6.07 | 7.93 | 6.90 | 7.62 | 4.44 | 9.99 | ||||||||||
| Net Income | 12.96 | 18.72 | 17.91 | 19.59 | 19.41 | 20.67 | 20.53 | 23.93 | 15.24 | 41.71 | ||||||||||
| EPS | 4.09 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 | 12.86 |
KRSNAA Company Updates
FY 2026FY 2026
Investor Presentation
May 25PDF
Feb 5PDF
Nov 7PDF
Aug 11PDF
KRSNAA Stock Peers
KRSNAA Past Performance & Peer Comparison
KRSNAA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krsnaa Diagnostics Ltd | 16.99 | 1.95 | 0.37% |
| Apollo Hospitals Enterprise Ltd | 62.87 | 11.00 | 0.24% |
| Max Healthcare Institute Ltd | 73.87 | 11.36 | 0.18% |
| Fortis Healthcare Ltd | 69.78 | 7.93 | 0.10% |
KRSNAA Stock Price Comparison
Compare KRSNAA with any stock or ETFCompare KRSNAA with any stock or ETF
KRSNAA
KRSNAA Holdings
KRSNAA Shareholdings
KRSNAA Promoter Holdings Trend
KRSNAA Promoter Holdings Trend
KRSNAA Institutional Holdings Trend
KRSNAA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
KRSNAA Shareholding Pattern
KRSNAA Shareholding Pattern
KRSNAA Shareholding History
KRSNAA Shareholding History
Foreign Institutions
Mutual Funds Invested in KRSNAA
Mutual Funds Invested in KRSNAA
No mutual funds holding trends are available
Top 5 Mutual Funds holding Krsnaa Diagnostics Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 8.3147% | Percentage of the fund’s portfolio invested in the stock 1.23% | Change in the portfolio weight of the stock over the last 3 months -0.32% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/68 (-8) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.0434% | Percentage of the fund’s portfolio invested in the stock 0.13% | Change in the portfolio weight of the stock over the last 3 months -0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 66/273 (+16) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1409% | Percentage of the fund’s portfolio invested in the stock 1.42% | Change in the portfolio weight of the stock over the last 3 months -0.31% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 33/46 (-9) |
Compare 3-month MF holding change on Screener
smallcases containing KRSNAA stock
smallcases containing KRSNAA stock
Looks like this stock is not in any smallcase yet.
KRSNAA Events
KRSNAA Events
KRSNAA Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KRSNAA has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.37%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.75 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
KRSNAA Dividend Trend
No Trend In Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
KRSNAA has shown inconsistent dividend trend over the last 5 years
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.37%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹3.75 every year
KRSNAA Upcoming Dividends
KRSNAA Upcoming Dividends
No upcoming dividends are available
KRSNAA Past Dividends
KRSNAA Past Dividends
Cash Dividend
Ex DateEx DateSep 12, 2025
Final
Final | Div/Share: ₹2.75
Dividend/Share
₹2.75
Ex DateEx Date
Sep 12, 2025
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹2.75
Dividend/Share
₹2.75
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
KRSNAA Stock News & Opinions
KRSNAA Stock News & Opinions
Articles & Videos
Spotlight
Spotlight
Krsnaa Diagnostics Q4 PAT climbs 102% YoY to Rs 42 crRevenue from operations jumped by 3.5% year-on-year (YoY) to Rs 192.60 crore in the quarter ended 31 March 2026. Profit before tax in Q4 FY26 stood at Rs 51.70 crore, up by 80.71% from Rs 28.61 crore in Q4 FY25. On a full-year basis, the company's consolidated net profit jumped 30.69% to Rs 101.43 crore on a 7.75% rise in net sales to Rs 772.77 crore in FY26 over FY25. Mitesh Dave, Group CEO, said, 'FY2026 represents a pivotal inflection point in Krsnaa Diagnostics' growth journey, marked not only by strong headline financial performance but more significantly by the accelerated emergence of our retail diagnostics vertical, Krsnaa Retail, as a structurally important and independently scalable growth engine for the group. Within just twelve months of focused scaling, our retail vertical delivered an 8 times jump in revenue and a 7 times surge in touchpoints, expanding to 3,500 locations across 5 states, a pace of growth that firmly establishes Krsnaa Retail as one of the country's most formidable retail diagnostics growth stories. As we enter FY2027, we remain focused on disciplined execution, transparency, and strong governance standards while continuing to uphold the trust placed in us by our investors, partners, and patients. The company has recommended a final dividend of Rs 2 per equity share of face value Rs 5 each (40% of face value) for FY26, subject to shareholders' approval at the ensuing AGM. Krsnaa Diagnostics is an integrated diagnostics service provider in India, offering technology-enabled diagnostic services including radiology, pathology, tele-radiology, and clinical laboratory services to public and private healthcare institutions across the country. Shares of Krsnaa Diagnostics shed 0.27% to Rs 553.65 on the BSE.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Corporate
Board of Krsnaa Diagnostics recommends final dividendKrsnaa Diagnostics announced that the Board of Directors of the Company at its meeting held on 25 May 2026, inter alia, have recommended the final dividend of Rs 2 per equity Share (i.e. 40%) , subject to the approval of the shareholders.
3 weeks agoCapital Market - Live
Earnings
Earnings
Krsnaa Diagnostics consolidated net profit rises 101.74% in the March 2026 quarterNet profit of Krsnaa Diagnostics rose 101.74% to Rs 41.72 crore in the quarter ended March 2026 as against Rs 20.68 crore during the previous quarter ended March 2025. Sales rose 3.50% to Rs 192.60 crore in the quarter ended March 2026 as against Rs 186.08 crore during the previous quarter ended March 2025. For the full year,net profit rose 30.69% to Rs 101.43 crore in the year ended March 2026 as against Rs 77.61 crore during the previous year ended March 2025. Sales rose 7.75% to Rs 772.77 crore in the year ended March 2026 as against Rs 717.16 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales192.60186.08 4 772.77717.16 8 OPM %28.4928.47 -27.4126.51 - PBDT74.2950.56 47 220.83191.01 16 PBT51.7028.61 81 130.37102.69 27 NP41.7220.68 102 101.4377.61 31 Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Corporate
Krsnaa Diagnostics to announce Quarterly ResultKrsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 25 May 2026.
1 month agoCapital Market - Live
Earnings
Earnings
Krsnaa Diagnostics consolidated net profit declines 21.47% in the December 2025 quarterNet profit of Krsnaa Diagnostics declined 21.47% to Rs 15.25 crore in the quarter ended December 2025 as against Rs 19.42 crore during the previous quarter ended December 2024. Sales rose 3.83% to Rs 181.20 crore in the quarter ended December 2025 as against Rs 174.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales181.20174.51 4 OPM %25.5825.83 - PBDT42.3448.18 -12 PBT19.6825.48 -23 NP15.2519.42 -21 Powered by Capital Market - Live
4 months agoCapital Market - Live
Earnings
Earnings
Krsnaa Diagnostics standalone net profit declines 23.66% in the December 2025 quarterNet profit of Krsnaa Diagnostics declined 23.66% to Rs 16.49 crore in the quarter ended December 2025 as against Rs 21.60 crore during the previous quarter ended December 2024. Sales declined 3.47% to Rs 159.43 crore in the quarter ended December 2025 as against Rs 165.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales159.43165.16 -3 OPM %29.9029.00 - PBDT43.7551.06 -14 PBT21.2228.37 -25 NP16.4921.60 -24 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Krsnaa Diagnostics schedules board meetingKrsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Corporate
Krsnaa Diagnostics schedules board meetingKrsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 12 December 2025.Powered by Capital Market - Live
6 months agoCapital Market - Live
Earnings
Earnings
Krsnaa Diagnostics consolidated net profit rises 22.19% in the September 2025 quarterNet profit of Krsnaa Diagnostics rose 22.19% to Rs 23.95 crore in the quarter ended September 2025 as against Rs 19.60 crore during the previous quarter ended September 2024. Sales rose 10.55% to Rs 205.99 crore in the quarter ended September 2025 as against Rs 186.34 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales205.99186.34 11 OPM %28.7226.51 - PBDT55.1547.61 16 PBT31.5625.40 24 NP23.9519.60 22 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Corporate
Krsnaa Diagnostics to table resultsKrsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant